nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A4—breast cancer	0.12	0.546	CbGaD
Boceprevir—ABCB1—breast cancer	0.0998	0.454	CbGaD
Boceprevir—CYP3A5—Lapatinib—breast cancer	0.0293	0.0808	CbGbCtD
Boceprevir—ABCB1—Toremifene—breast cancer	0.0261	0.0721	CbGbCtD
Boceprevir—CYP3A4—Exemestane—breast cancer	0.0226	0.0623	CbGbCtD
Boceprevir—CYP3A4—Letrozole—breast cancer	0.0192	0.053	CbGbCtD
Boceprevir—ABCB1—Lapatinib—breast cancer	0.019	0.0526	CbGbCtD
Boceprevir—CYP3A4—Anastrozole—breast cancer	0.0171	0.0472	CbGbCtD
Boceprevir—CYP3A4—Toremifene—breast cancer	0.0156	0.0432	CbGbCtD
Boceprevir—CYP3A5—Tamoxifen—breast cancer	0.0146	0.0405	CbGbCtD
Boceprevir—CYP3A4—Fulvestrant—breast cancer	0.0145	0.0402	CbGbCtD
Boceprevir—CYP3A4—Thiotepa—breast cancer	0.013	0.0358	CbGbCtD
Boceprevir—CYP3A4—Ixabepilone—breast cancer	0.0119	0.0327	CbGbCtD
Boceprevir—CYP3A4—Lapatinib—breast cancer	0.0114	0.0315	CbGbCtD
Boceprevir—CYP3A5—Paclitaxel—breast cancer	0.0114	0.0315	CbGbCtD
Boceprevir—CYP3A5—Irinotecan—breast cancer	0.0112	0.0311	CbGbCtD
Boceprevir—ABCB1—Vinorelbine—breast cancer	0.0106	0.0292	CbGbCtD
Boceprevir—ABCB1—Tamoxifen—breast cancer	0.00953	0.0263	CbGbCtD
Boceprevir—ABCB1—Mitoxantrone—breast cancer	0.0093	0.0257	CbGbCtD
Boceprevir—CYP3A4—Raloxifene—breast cancer	0.00865	0.0239	CbGbCtD
Boceprevir—CYP3A5—Docetaxel—breast cancer	0.00824	0.0228	CbGbCtD
Boceprevir—ABCB1—Gemcitabine—breast cancer	0.00821	0.0227	CbGbCtD
Boceprevir—ABCB1—Paclitaxel—breast cancer	0.00742	0.0205	CbGbCtD
Boceprevir—ABCB1—Irinotecan—breast cancer	0.00732	0.0202	CbGbCtD
Boceprevir—ABCB1—Vinblastine—breast cancer	0.00651	0.018	CbGbCtD
Boceprevir—CYP3A4—Vinorelbine—breast cancer	0.00633	0.0175	CbGbCtD
Boceprevir—CYP3A4—Tamoxifen—breast cancer	0.00571	0.0158	CbGbCtD
Boceprevir—CYP3A4—Mitoxantrone—breast cancer	0.00557	0.0154	CbGbCtD
Boceprevir—ABCB1—Docetaxel—breast cancer	0.00537	0.0148	CbGbCtD
Boceprevir—CYP3A4—Paclitaxel—breast cancer	0.00445	0.0123	CbGbCtD
Boceprevir—CYP3A4—Irinotecan—breast cancer	0.00439	0.0121	CbGbCtD
Boceprevir—ABCB1—Doxorubicin—breast cancer	0.004	0.0111	CbGbCtD
Boceprevir—CYP3A4—Vinblastine—breast cancer	0.0039	0.0108	CbGbCtD
Boceprevir—ABCB1—Methotrexate—breast cancer	0.00387	0.0107	CbGbCtD
Boceprevir—CTSV—nipple—breast cancer	0.00324	0.0414	CbGeAlD
Boceprevir—CYP3A4—Docetaxel—breast cancer	0.00321	0.00888	CbGbCtD
Boceprevir—CTSK—Estradiol—Fulvestrant—breast cancer	0.00304	0.865	CbGdCrCtD
Boceprevir—CTSL—nipple—breast cancer	0.00264	0.0338	CbGeAlD
Boceprevir—CTSK—mammary gland—breast cancer	0.00241	0.0308	CbGeAlD
Boceprevir—CYP3A4—Doxorubicin—breast cancer	0.0024	0.00662	CbGbCtD
Boceprevir—CTSL—embryo—breast cancer	0.00218	0.0279	CbGeAlD
Boceprevir—CTSV—skin of body—breast cancer	0.00207	0.0265	CbGeAlD
Boceprevir—CTSK—nipple—breast cancer	0.00199	0.0254	CbGeAlD
Boceprevir—CMA1—skin of body—breast cancer	0.00198	0.0253	CbGeAlD
Boceprevir—CTSV—endometrium—breast cancer	0.00195	0.025	CbGeAlD
Boceprevir—CTSL—epithelium—breast cancer	0.00178	0.0227	CbGeAlD
Boceprevir—CTSV—pituitary gland—breast cancer	0.00177	0.0226	CbGeAlD
Boceprevir—CTSV—adipose tissue—breast cancer	0.00176	0.0225	CbGeAlD
Boceprevir—CTSS—nipple—breast cancer	0.00175	0.0223	CbGeAlD
Boceprevir—CTSL—skin of body—breast cancer	0.00169	0.0216	CbGeAlD
Boceprevir—CMA1—adipose tissue—breast cancer	0.00168	0.0215	CbGeAlD
Boceprevir—CTSV—female reproductive system—breast cancer	0.00162	0.0207	CbGeAlD
Boceprevir—CTSL—endometrium—breast cancer	0.0016	0.0204	CbGeAlD
Boceprevir—CMA1—female reproductive system—breast cancer	0.00155	0.0198	CbGeAlD
Boceprevir—CMA1—adrenal gland—breast cancer	0.00151	0.0193	CbGeAlD
Boceprevir—CTSV—female gonad—breast cancer	0.00147	0.0188	CbGeAlD
Boceprevir—CTSL—uterus—breast cancer	0.00147	0.0188	CbGeAlD
Boceprevir—CMA1—bone marrow—breast cancer	0.00146	0.0186	CbGeAlD
Boceprevir—CTSL—pituitary gland—breast cancer	0.00144	0.0185	CbGeAlD
Boceprevir—CTSS—embryo—breast cancer	0.00144	0.0184	CbGeAlD
Boceprevir—CTSL—adipose tissue—breast cancer	0.00144	0.0184	CbGeAlD
Boceprevir—CTSV—endocrine gland—breast cancer	0.00137	0.0175	CbGeAlD
Boceprevir—CTSL—female reproductive system—breast cancer	0.00132	0.0169	CbGeAlD
Boceprevir—CMA1—endocrine gland—breast cancer	0.00131	0.0167	CbGeAlD
Boceprevir—CTSL—adrenal gland—breast cancer	0.00129	0.0165	CbGeAlD
Boceprevir—CTSK—skin of body—breast cancer	0.00128	0.0163	CbGeAlD
Boceprevir—CTSL—bone marrow—breast cancer	0.00125	0.0159	CbGeAlD
Boceprevir—CTSL—female gonad—breast cancer	0.0012	0.0154	CbGeAlD
Boceprevir—CTSK—endometrium—breast cancer	0.0012	0.0154	CbGeAlD
Boceprevir—CTSL—endocrine gland—breast cancer	0.00112	0.0143	CbGeAlD
Boceprevir—CTSS—skin of body—breast cancer	0.00112	0.0143	CbGeAlD
Boceprevir—CTSK—uterus—breast cancer	0.00111	0.0142	CbGeAlD
Boceprevir—CTSK—pituitary gland—breast cancer	0.00109	0.0139	CbGeAlD
Boceprevir—CTSK—adipose tissue—breast cancer	0.00108	0.0138	CbGeAlD
Boceprevir—CTSS—endometrium—breast cancer	0.00105	0.0135	CbGeAlD
Boceprevir—CTSK—female reproductive system—breast cancer	0.000996	0.0127	CbGeAlD
Boceprevir—CTSK—adrenal gland—breast cancer	0.000972	0.0124	CbGeAlD
Boceprevir—CTSS—uterus—breast cancer	0.000971	0.0124	CbGeAlD
Boceprevir—CTSS—pituitary gland—breast cancer	0.000954	0.0122	CbGeAlD
Boceprevir—CTSS—adipose tissue—breast cancer	0.00095	0.0121	CbGeAlD
Boceprevir—CTSK—bone marrow—breast cancer	0.00094	0.012	CbGeAlD
Boceprevir—CTSK—female gonad—breast cancer	0.000906	0.0116	CbGeAlD
Boceprevir—CMA1—lymph node—breast cancer	0.000904	0.0116	CbGeAlD
Boceprevir—Telaprevir—CYP3A4—breast cancer	0.000888	0.37	CrCbGaD
Boceprevir—CTSS—female reproductive system—breast cancer	0.000873	0.0112	CbGeAlD
Boceprevir—CTSS—adrenal gland—breast cancer	0.000852	0.0109	CbGeAlD
Boceprevir—CTSK—endocrine gland—breast cancer	0.000843	0.0108	CbGeAlD
Boceprevir—CTSS—bone marrow—breast cancer	0.000824	0.0105	CbGeAlD
Boceprevir—CTSS—female gonad—breast cancer	0.000794	0.0101	CbGeAlD
Boceprevir—Telaprevir—ALB—breast cancer	0.000774	0.323	CrCbGaD
Boceprevir—CTSL—lymph node—breast cancer	0.000773	0.00988	CbGeAlD
Boceprevir—Telaprevir—ABCB1—breast cancer	0.000739	0.308	CrCbGaD
Boceprevir—CTSS—endocrine gland—breast cancer	0.000739	0.00944	CbGeAlD
Boceprevir—CTSK—lymph node—breast cancer	0.000583	0.00745	CbGeAlD
Boceprevir—CTSS—lymph node—breast cancer	0.000511	0.00652	CbGeAlD
Boceprevir—CYP3A5—adipose tissue—breast cancer	0.000315	0.00403	CbGeAlD
Boceprevir—CYP3A5—female gonad—breast cancer	0.000264	0.00337	CbGeAlD
Boceprevir—ABCB1—embryo—breast cancer	0.000254	0.00325	CbGeAlD
Boceprevir—CYP3A5—endocrine gland—breast cancer	0.000245	0.00313	CbGeAlD
Boceprevir—CTSL—Betamethasone—Fluoxymesterone—breast cancer	0.000238	0.0677	CbGdCrCtD
Boceprevir—CTSL—Dexamethasone—Fluoxymesterone—breast cancer	0.000238	0.0677	CbGdCrCtD
Boceprevir—CYP3A4—female reproductive system—breast cancer	0.000218	0.00278	CbGeAlD
Boceprevir—ABCB1—epithelium—breast cancer	0.000207	0.00265	CbGeAlD
Boceprevir—ABCB1—endometrium—breast cancer	0.000186	0.00238	CbGeAlD
Boceprevir—CYP3A4—endocrine gland—breast cancer	0.000184	0.00235	CbGeAlD
Boceprevir—ABCB1—uterus—breast cancer	0.000171	0.00219	CbGeAlD
Boceprevir—ABCB1—pituitary gland—breast cancer	0.000168	0.00215	CbGeAlD
Boceprevir—ABCB1—adipose tissue—breast cancer	0.000168	0.00214	CbGeAlD
Boceprevir—ABCB1—female reproductive system—breast cancer	0.000154	0.00197	CbGeAlD
Boceprevir—ABCB1—adrenal gland—breast cancer	0.00015	0.00192	CbGeAlD
Boceprevir—ABCB1—bone marrow—breast cancer	0.000145	0.00186	CbGeAlD
Boceprevir—ABCB1—female gonad—breast cancer	0.00014	0.00179	CbGeAlD
Boceprevir—ABCB1—endocrine gland—breast cancer	0.00013	0.00167	CbGeAlD
Boceprevir—ABCB1—lymph node—breast cancer	9.01e-05	0.00115	CbGeAlD
Boceprevir—Dyspepsia—Docetaxel—breast cancer	2.6e-05	0.000131	CcSEcCtD
Boceprevir—Insomnia—Capecitabine—breast cancer	2.59e-05	0.00013	CcSEcCtD
Boceprevir—Hypoaesthesia—Doxorubicin—breast cancer	2.59e-05	0.00013	CcSEcCtD
Boceprevir—Rash—Fluorouracil—breast cancer	2.58e-05	0.00013	CcSEcCtD
Boceprevir—Dermatitis—Fluorouracil—breast cancer	2.58e-05	0.00013	CcSEcCtD
Boceprevir—Pharyngitis—Doxorubicin—breast cancer	2.58e-05	0.000129	CcSEcCtD
Boceprevir—Paraesthesia—Capecitabine—breast cancer	2.57e-05	0.000129	CcSEcCtD
Boceprevir—Decreased appetite—Docetaxel—breast cancer	2.57e-05	0.000129	CcSEcCtD
Boceprevir—Hypersensitivity—Paclitaxel—breast cancer	2.57e-05	0.000129	CcSEcCtD
Boceprevir—Headache—Fluorouracil—breast cancer	2.57e-05	0.000129	CcSEcCtD
Boceprevir—Urinary tract disorder—Doxorubicin—breast cancer	2.57e-05	0.000129	CcSEcCtD
Boceprevir—Oedema peripheral—Doxorubicin—breast cancer	2.56e-05	0.000129	CcSEcCtD
Boceprevir—Dysgeusia—Methotrexate—breast cancer	2.56e-05	0.000128	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Docetaxel—breast cancer	2.55e-05	0.000128	CcSEcCtD
Boceprevir—Connective tissue disorder—Doxorubicin—breast cancer	2.55e-05	0.000128	CcSEcCtD
Boceprevir—Dyspnoea—Capecitabine—breast cancer	2.55e-05	0.000128	CcSEcCtD
Boceprevir—Fatigue—Docetaxel—breast cancer	2.55e-05	0.000128	CcSEcCtD
Boceprevir—Angiopathy—Epirubicin—breast cancer	2.55e-05	0.000128	CcSEcCtD
Boceprevir—Urethral disorder—Doxorubicin—breast cancer	2.55e-05	0.000128	CcSEcCtD
Boceprevir—Nausea—Mitoxantrone—breast cancer	2.54e-05	0.000128	CcSEcCtD
Boceprevir—Nausea—Irinotecan—breast cancer	2.54e-05	0.000128	CcSEcCtD
Boceprevir—Immune system disorder—Epirubicin—breast cancer	2.54e-05	0.000127	CcSEcCtD
Boceprevir—Mediastinal disorder—Epirubicin—breast cancer	2.53e-05	0.000127	CcSEcCtD
Boceprevir—Pain—Docetaxel—breast cancer	2.53e-05	0.000127	CcSEcCtD
Boceprevir—Constipation—Docetaxel—breast cancer	2.53e-05	0.000127	CcSEcCtD
Boceprevir—Back pain—Methotrexate—breast cancer	2.53e-05	0.000127	CcSEcCtD
Boceprevir—Dyspepsia—Capecitabine—breast cancer	2.52e-05	0.000127	CcSEcCtD
Boceprevir—Chills—Epirubicin—breast cancer	2.52e-05	0.000127	CcSEcCtD
Boceprevir—Arrhythmia—Epirubicin—breast cancer	2.51e-05	0.000126	CcSEcCtD
Boceprevir—Visual impairment—Doxorubicin—breast cancer	2.5e-05	0.000126	CcSEcCtD
Boceprevir—Asthenia—Paclitaxel—breast cancer	2.5e-05	0.000126	CcSEcCtD
Boceprevir—Decreased appetite—Capecitabine—breast cancer	2.49e-05	0.000125	CcSEcCtD
Boceprevir—Alopecia—Epirubicin—breast cancer	2.48e-05	0.000125	CcSEcCtD
Boceprevir—Nausea—Gemcitabine—breast cancer	2.48e-05	0.000124	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Capecitabine—breast cancer	2.47e-05	0.000124	CcSEcCtD
Boceprevir—Fatigue—Capecitabine—breast cancer	2.47e-05	0.000124	CcSEcCtD
Boceprevir—Pruritus—Paclitaxel—breast cancer	2.47e-05	0.000124	CcSEcCtD
Boceprevir—Vision blurred—Methotrexate—breast cancer	2.46e-05	0.000124	CcSEcCtD
Boceprevir—Mental disorder—Epirubicin—breast cancer	2.46e-05	0.000124	CcSEcCtD
Boceprevir—Erythema multiforme—Doxorubicin—breast cancer	2.46e-05	0.000123	CcSEcCtD
Boceprevir—Pain—Capecitabine—breast cancer	2.45e-05	0.000123	CcSEcCtD
Boceprevir—Constipation—Capecitabine—breast cancer	2.45e-05	0.000123	CcSEcCtD
Boceprevir—Erythema—Epirubicin—breast cancer	2.45e-05	0.000123	CcSEcCtD
Boceprevir—Malnutrition—Epirubicin—breast cancer	2.45e-05	0.000123	CcSEcCtD
Boceprevir—Feeling abnormal—Docetaxel—breast cancer	2.44e-05	0.000122	CcSEcCtD
Boceprevir—Nausea—Fluorouracil—breast cancer	2.44e-05	0.000122	CcSEcCtD
Boceprevir—Eye disorder—Doxorubicin—breast cancer	2.43e-05	0.000122	CcSEcCtD
Boceprevir—Ill-defined disorder—Methotrexate—breast cancer	2.42e-05	0.000122	CcSEcCtD
Boceprevir—Tinnitus—Doxorubicin—breast cancer	2.42e-05	0.000122	CcSEcCtD
Boceprevir—Gastrointestinal pain—Docetaxel—breast cancer	2.42e-05	0.000121	CcSEcCtD
Boceprevir—Anaemia—Methotrexate—breast cancer	2.42e-05	0.000121	CcSEcCtD
Boceprevir—Cardiac disorder—Doxorubicin—breast cancer	2.41e-05	0.000121	CcSEcCtD
Boceprevir—Flushing—Doxorubicin—breast cancer	2.41e-05	0.000121	CcSEcCtD
Boceprevir—Flatulence—Epirubicin—breast cancer	2.41e-05	0.000121	CcSEcCtD
Boceprevir—Dysgeusia—Epirubicin—breast cancer	2.39e-05	0.00012	CcSEcCtD
Boceprevir—Diarrhoea—Paclitaxel—breast cancer	2.39e-05	0.00012	CcSEcCtD
Boceprevir—Back pain—Epirubicin—breast cancer	2.37e-05	0.000119	CcSEcCtD
Boceprevir—Feeling abnormal—Capecitabine—breast cancer	2.36e-05	0.000119	CcSEcCtD
Boceprevir—Angiopathy—Doxorubicin—breast cancer	2.36e-05	0.000118	CcSEcCtD
Boceprevir—Malaise—Methotrexate—breast cancer	2.36e-05	0.000118	CcSEcCtD
Boceprevir—Muscle spasms—Epirubicin—breast cancer	2.35e-05	0.000118	CcSEcCtD
Boceprevir—Immune system disorder—Doxorubicin—breast cancer	2.35e-05	0.000118	CcSEcCtD
Boceprevir—Vertigo—Methotrexate—breast cancer	2.35e-05	0.000118	CcSEcCtD
Boceprevir—Gastrointestinal pain—Capecitabine—breast cancer	2.34e-05	0.000118	CcSEcCtD
Boceprevir—Mediastinal disorder—Doxorubicin—breast cancer	2.34e-05	0.000118	CcSEcCtD
Boceprevir—Body temperature increased—Docetaxel—breast cancer	2.34e-05	0.000117	CcSEcCtD
Boceprevir—Abdominal pain—Docetaxel—breast cancer	2.34e-05	0.000117	CcSEcCtD
Boceprevir—Leukopenia—Methotrexate—breast cancer	2.34e-05	0.000117	CcSEcCtD
Boceprevir—Chills—Doxorubicin—breast cancer	2.33e-05	0.000117	CcSEcCtD
Boceprevir—Arrhythmia—Doxorubicin—breast cancer	2.32e-05	0.000117	CcSEcCtD
Boceprevir—Dizziness—Paclitaxel—breast cancer	2.31e-05	0.000116	CcSEcCtD
Boceprevir—Vision blurred—Epirubicin—breast cancer	2.3e-05	0.000116	CcSEcCtD
Boceprevir—Alopecia—Doxorubicin—breast cancer	2.3e-05	0.000115	CcSEcCtD
Boceprevir—Cough—Methotrexate—breast cancer	2.28e-05	0.000114	CcSEcCtD
Boceprevir—Mental disorder—Doxorubicin—breast cancer	2.28e-05	0.000114	CcSEcCtD
Boceprevir—Urticaria—Capecitabine—breast cancer	2.28e-05	0.000114	CcSEcCtD
Boceprevir—Ill-defined disorder—Epirubicin—breast cancer	2.27e-05	0.000114	CcSEcCtD
Boceprevir—Abdominal pain—Capecitabine—breast cancer	2.26e-05	0.000114	CcSEcCtD
Boceprevir—Body temperature increased—Capecitabine—breast cancer	2.26e-05	0.000114	CcSEcCtD
Boceprevir—Malnutrition—Doxorubicin—breast cancer	2.26e-05	0.000114	CcSEcCtD
Boceprevir—Erythema—Doxorubicin—breast cancer	2.26e-05	0.000114	CcSEcCtD
Boceprevir—Anaemia—Epirubicin—breast cancer	2.26e-05	0.000113	CcSEcCtD
Boceprevir—Agitation—Epirubicin—breast cancer	2.25e-05	0.000113	CcSEcCtD
Boceprevir—Flatulence—Doxorubicin—breast cancer	2.23e-05	0.000112	CcSEcCtD
Boceprevir—Chest pain—Methotrexate—breast cancer	2.22e-05	0.000112	CcSEcCtD
Boceprevir—Myalgia—Methotrexate—breast cancer	2.22e-05	0.000112	CcSEcCtD
Boceprevir—Arthralgia—Methotrexate—breast cancer	2.22e-05	0.000112	CcSEcCtD
Boceprevir—Vomiting—Paclitaxel—breast cancer	2.22e-05	0.000111	CcSEcCtD
Boceprevir—Dysgeusia—Doxorubicin—breast cancer	2.22e-05	0.000111	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.21e-05	0.000111	CcSEcCtD
Boceprevir—Malaise—Epirubicin—breast cancer	2.21e-05	0.000111	CcSEcCtD
Boceprevir—Rash—Paclitaxel—breast cancer	2.2e-05	0.00011	CcSEcCtD
Boceprevir—Dermatitis—Paclitaxel—breast cancer	2.2e-05	0.00011	CcSEcCtD
Boceprevir—Discomfort—Methotrexate—breast cancer	2.2e-05	0.00011	CcSEcCtD
Boceprevir—Vertigo—Epirubicin—breast cancer	2.2e-05	0.00011	CcSEcCtD
Boceprevir—Syncope—Epirubicin—breast cancer	2.19e-05	0.00011	CcSEcCtD
Boceprevir—Leukopenia—Epirubicin—breast cancer	2.19e-05	0.00011	CcSEcCtD
Boceprevir—Back pain—Doxorubicin—breast cancer	2.19e-05	0.00011	CcSEcCtD
Boceprevir—Headache—Paclitaxel—breast cancer	2.19e-05	0.00011	CcSEcCtD
Boceprevir—Hypersensitivity—Docetaxel—breast cancer	2.18e-05	0.000109	CcSEcCtD
Boceprevir—Muscle spasms—Doxorubicin—breast cancer	2.18e-05	0.000109	CcSEcCtD
Boceprevir—Palpitations—Epirubicin—breast cancer	2.16e-05	0.000108	CcSEcCtD
Boceprevir—Confusional state—Methotrexate—breast cancer	2.15e-05	0.000108	CcSEcCtD
Boceprevir—Loss of consciousness—Epirubicin—breast cancer	2.15e-05	0.000108	CcSEcCtD
Boceprevir—Cough—Epirubicin—breast cancer	2.13e-05	0.000107	CcSEcCtD
Boceprevir—Vision blurred—Doxorubicin—breast cancer	2.13e-05	0.000107	CcSEcCtD
Boceprevir—Asthenia—Docetaxel—breast cancer	2.12e-05	0.000107	CcSEcCtD
Boceprevir—Infection—Methotrexate—breast cancer	2.12e-05	0.000106	CcSEcCtD
Boceprevir—Hypertension—Epirubicin—breast cancer	2.11e-05	0.000106	CcSEcCtD
Boceprevir—Hypersensitivity—Capecitabine—breast cancer	2.11e-05	0.000106	CcSEcCtD
Boceprevir—Ill-defined disorder—Doxorubicin—breast cancer	2.1e-05	0.000105	CcSEcCtD
Boceprevir—Pruritus—Docetaxel—breast cancer	2.09e-05	0.000105	CcSEcCtD
Boceprevir—Nervous system disorder—Methotrexate—breast cancer	2.09e-05	0.000105	CcSEcCtD
Boceprevir—Anaemia—Doxorubicin—breast cancer	2.09e-05	0.000105	CcSEcCtD
Boceprevir—Thrombocytopenia—Methotrexate—breast cancer	2.09e-05	0.000105	CcSEcCtD
Boceprevir—Chest pain—Epirubicin—breast cancer	2.08e-05	0.000105	CcSEcCtD
Boceprevir—Arthralgia—Epirubicin—breast cancer	2.08e-05	0.000105	CcSEcCtD
Boceprevir—Myalgia—Epirubicin—breast cancer	2.08e-05	0.000105	CcSEcCtD
Boceprevir—Agitation—Doxorubicin—breast cancer	2.08e-05	0.000104	CcSEcCtD
Boceprevir—Anxiety—Epirubicin—breast cancer	2.07e-05	0.000104	CcSEcCtD
Boceprevir—Nausea—Paclitaxel—breast cancer	2.07e-05	0.000104	CcSEcCtD
Boceprevir—Skin disorder—Methotrexate—breast cancer	2.07e-05	0.000104	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.07e-05	0.000104	CcSEcCtD
Boceprevir—Hyperhidrosis—Methotrexate—breast cancer	2.06e-05	0.000103	CcSEcCtD
Boceprevir—Discomfort—Epirubicin—breast cancer	2.06e-05	0.000103	CcSEcCtD
Boceprevir—Asthenia—Capecitabine—breast cancer	2.06e-05	0.000103	CcSEcCtD
Boceprevir—Malaise—Doxorubicin—breast cancer	2.04e-05	0.000102	CcSEcCtD
Boceprevir—Dry mouth—Epirubicin—breast cancer	2.04e-05	0.000102	CcSEcCtD
Boceprevir—Vertigo—Doxorubicin—breast cancer	2.03e-05	0.000102	CcSEcCtD
Boceprevir—Syncope—Doxorubicin—breast cancer	2.03e-05	0.000102	CcSEcCtD
Boceprevir—Pruritus—Capecitabine—breast cancer	2.03e-05	0.000102	CcSEcCtD
Boceprevir—Leukopenia—Doxorubicin—breast cancer	2.03e-05	0.000102	CcSEcCtD
Boceprevir—Diarrhoea—Docetaxel—breast cancer	2.02e-05	0.000102	CcSEcCtD
Boceprevir—Confusional state—Epirubicin—breast cancer	2.01e-05	0.000101	CcSEcCtD
Boceprevir—Palpitations—Doxorubicin—breast cancer	2e-05	0.0001	CcSEcCtD
Boceprevir—Hypotension—Methotrexate—breast cancer	1.99e-05	0.0001	CcSEcCtD
Boceprevir—Loss of consciousness—Doxorubicin—breast cancer	1.99e-05	9.98e-05	CcSEcCtD
Boceprevir—Infection—Epirubicin—breast cancer	1.98e-05	9.95e-05	CcSEcCtD
Boceprevir—Cough—Doxorubicin—breast cancer	1.97e-05	9.91e-05	CcSEcCtD
Boceprevir—Shock—Epirubicin—breast cancer	1.96e-05	9.86e-05	CcSEcCtD
Boceprevir—Diarrhoea—Capecitabine—breast cancer	1.96e-05	9.84e-05	CcSEcCtD
Boceprevir—Nervous system disorder—Epirubicin—breast cancer	1.96e-05	9.82e-05	CcSEcCtD
Boceprevir—Dizziness—Docetaxel—breast cancer	1.96e-05	9.82e-05	CcSEcCtD
Boceprevir—Thrombocytopenia—Epirubicin—breast cancer	1.95e-05	9.81e-05	CcSEcCtD
Boceprevir—Hypertension—Doxorubicin—breast cancer	1.95e-05	9.81e-05	CcSEcCtD
Boceprevir—Tachycardia—Epirubicin—breast cancer	1.95e-05	9.78e-05	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Methotrexate—breast cancer	1.94e-05	9.75e-05	CcSEcCtD
Boceprevir—Skin disorder—Epirubicin—breast cancer	1.94e-05	9.73e-05	CcSEcCtD
Boceprevir—Hyperhidrosis—Epirubicin—breast cancer	1.93e-05	9.68e-05	CcSEcCtD
Boceprevir—Insomnia—Methotrexate—breast cancer	1.93e-05	9.68e-05	CcSEcCtD
Boceprevir—Arthralgia—Doxorubicin—breast cancer	1.93e-05	9.67e-05	CcSEcCtD
Boceprevir—Chest pain—Doxorubicin—breast cancer	1.93e-05	9.67e-05	CcSEcCtD
Boceprevir—Myalgia—Doxorubicin—breast cancer	1.93e-05	9.67e-05	CcSEcCtD
Boceprevir—Anxiety—Doxorubicin—breast cancer	1.92e-05	9.64e-05	CcSEcCtD
Boceprevir—Paraesthesia—Methotrexate—breast cancer	1.91e-05	9.61e-05	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.91e-05	9.6e-05	CcSEcCtD
Boceprevir—Discomfort—Doxorubicin—breast cancer	1.9e-05	9.55e-05	CcSEcCtD
Boceprevir—Dyspnoea—Methotrexate—breast cancer	1.9e-05	9.54e-05	CcSEcCtD
Boceprevir—Dizziness—Capecitabine—breast cancer	1.89e-05	9.51e-05	CcSEcCtD
Boceprevir—Dry mouth—Doxorubicin—breast cancer	1.88e-05	9.46e-05	CcSEcCtD
Boceprevir—Vomiting—Docetaxel—breast cancer	1.88e-05	9.44e-05	CcSEcCtD
Boceprevir—Dyspepsia—Methotrexate—breast cancer	1.88e-05	9.42e-05	CcSEcCtD
Boceprevir—Rash—Docetaxel—breast cancer	1.87e-05	9.36e-05	CcSEcCtD
Boceprevir—Hypotension—Epirubicin—breast cancer	1.86e-05	9.36e-05	CcSEcCtD
Boceprevir—Dermatitis—Docetaxel—breast cancer	1.86e-05	9.36e-05	CcSEcCtD
Boceprevir—Confusional state—Doxorubicin—breast cancer	1.86e-05	9.35e-05	CcSEcCtD
Boceprevir—Decreased appetite—Methotrexate—breast cancer	1.85e-05	9.31e-05	CcSEcCtD
Boceprevir—Headache—Docetaxel—breast cancer	1.85e-05	9.3e-05	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Methotrexate—breast cancer	1.84e-05	9.24e-05	CcSEcCtD
Boceprevir—Fatigue—Methotrexate—breast cancer	1.84e-05	9.23e-05	CcSEcCtD
Boceprevir—Infection—Doxorubicin—breast cancer	1.83e-05	9.21e-05	CcSEcCtD
Boceprevir—Pain—Methotrexate—breast cancer	1.82e-05	9.15e-05	CcSEcCtD
Boceprevir—Vomiting—Capecitabine—breast cancer	1.82e-05	9.14e-05	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Epirubicin—breast cancer	1.82e-05	9.13e-05	CcSEcCtD
Boceprevir—Shock—Doxorubicin—breast cancer	1.82e-05	9.12e-05	CcSEcCtD
Boceprevir—Nervous system disorder—Doxorubicin—breast cancer	1.81e-05	9.09e-05	CcSEcCtD
Boceprevir—Thrombocytopenia—Doxorubicin—breast cancer	1.81e-05	9.08e-05	CcSEcCtD
Boceprevir—Rash—Capecitabine—breast cancer	1.81e-05	9.07e-05	CcSEcCtD
Boceprevir—Insomnia—Epirubicin—breast cancer	1.81e-05	9.06e-05	CcSEcCtD
Boceprevir—Dermatitis—Capecitabine—breast cancer	1.8e-05	9.06e-05	CcSEcCtD
Boceprevir—Tachycardia—Doxorubicin—breast cancer	1.8e-05	9.05e-05	CcSEcCtD
Boceprevir—Headache—Capecitabine—breast cancer	1.79e-05	9.01e-05	CcSEcCtD
Boceprevir—Skin disorder—Doxorubicin—breast cancer	1.79e-05	9e-05	CcSEcCtD
Boceprevir—Paraesthesia—Epirubicin—breast cancer	1.79e-05	9e-05	CcSEcCtD
Boceprevir—Hyperhidrosis—Doxorubicin—breast cancer	1.79e-05	8.96e-05	CcSEcCtD
Boceprevir—Dyspnoea—Epirubicin—breast cancer	1.78e-05	8.93e-05	CcSEcCtD
Boceprevir—Nausea—Docetaxel—breast cancer	1.76e-05	8.82e-05	CcSEcCtD
Boceprevir—Feeling abnormal—Methotrexate—breast cancer	1.76e-05	8.82e-05	CcSEcCtD
Boceprevir—Dyspepsia—Epirubicin—breast cancer	1.76e-05	8.82e-05	CcSEcCtD
Boceprevir—Gastrointestinal pain—Methotrexate—breast cancer	1.74e-05	8.75e-05	CcSEcCtD
Boceprevir—Decreased appetite—Epirubicin—breast cancer	1.73e-05	8.71e-05	CcSEcCtD
Boceprevir—Hypotension—Doxorubicin—breast cancer	1.73e-05	8.66e-05	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Epirubicin—breast cancer	1.72e-05	8.65e-05	CcSEcCtD
Boceprevir—Fatigue—Epirubicin—breast cancer	1.72e-05	8.64e-05	CcSEcCtD
Boceprevir—Pain—Epirubicin—breast cancer	1.71e-05	8.57e-05	CcSEcCtD
Boceprevir—Constipation—Epirubicin—breast cancer	1.71e-05	8.57e-05	CcSEcCtD
Boceprevir—Nausea—Capecitabine—breast cancer	1.7e-05	8.54e-05	CcSEcCtD
Boceprevir—Urticaria—Methotrexate—breast cancer	1.69e-05	8.5e-05	CcSEcCtD
Boceprevir—Abdominal pain—Methotrexate—breast cancer	1.69e-05	8.46e-05	CcSEcCtD
Boceprevir—Body temperature increased—Methotrexate—breast cancer	1.69e-05	8.46e-05	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.68e-05	8.45e-05	CcSEcCtD
Boceprevir—Insomnia—Doxorubicin—breast cancer	1.67e-05	8.38e-05	CcSEcCtD
Boceprevir—Paraesthesia—Doxorubicin—breast cancer	1.66e-05	8.32e-05	CcSEcCtD
Boceprevir—Dyspnoea—Doxorubicin—breast cancer	1.65e-05	8.26e-05	CcSEcCtD
Boceprevir—Feeling abnormal—Epirubicin—breast cancer	1.64e-05	8.26e-05	CcSEcCtD
Boceprevir—Gastrointestinal pain—Epirubicin—breast cancer	1.63e-05	8.19e-05	CcSEcCtD
Boceprevir—Dyspepsia—Doxorubicin—breast cancer	1.63e-05	8.16e-05	CcSEcCtD
Boceprevir—Decreased appetite—Doxorubicin—breast cancer	1.61e-05	8.06e-05	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Doxorubicin—breast cancer	1.59e-05	8e-05	CcSEcCtD
Boceprevir—Fatigue—Doxorubicin—breast cancer	1.59e-05	7.99e-05	CcSEcCtD
Boceprevir—Urticaria—Epirubicin—breast cancer	1.59e-05	7.96e-05	CcSEcCtD
Boceprevir—Pain—Doxorubicin—breast cancer	1.58e-05	7.93e-05	CcSEcCtD
Boceprevir—Constipation—Doxorubicin—breast cancer	1.58e-05	7.93e-05	CcSEcCtD
Boceprevir—Abdominal pain—Epirubicin—breast cancer	1.58e-05	7.92e-05	CcSEcCtD
Boceprevir—Body temperature increased—Epirubicin—breast cancer	1.58e-05	7.92e-05	CcSEcCtD
Boceprevir—Hypersensitivity—Methotrexate—breast cancer	1.57e-05	7.89e-05	CcSEcCtD
Boceprevir—Asthenia—Methotrexate—breast cancer	1.53e-05	7.68e-05	CcSEcCtD
Boceprevir—Feeling abnormal—Doxorubicin—breast cancer	1.52e-05	7.64e-05	CcSEcCtD
Boceprevir—Gastrointestinal pain—Doxorubicin—breast cancer	1.51e-05	7.58e-05	CcSEcCtD
Boceprevir—Pruritus—Methotrexate—breast cancer	1.51e-05	7.57e-05	CcSEcCtD
Boceprevir—Hypersensitivity—Epirubicin—breast cancer	1.47e-05	7.38e-05	CcSEcCtD
Boceprevir—Urticaria—Doxorubicin—breast cancer	1.47e-05	7.36e-05	CcSEcCtD
Boceprevir—Abdominal pain—Doxorubicin—breast cancer	1.46e-05	7.33e-05	CcSEcCtD
Boceprevir—Body temperature increased—Doxorubicin—breast cancer	1.46e-05	7.33e-05	CcSEcCtD
Boceprevir—Diarrhoea—Methotrexate—breast cancer	1.46e-05	7.32e-05	CcSEcCtD
Boceprevir—Asthenia—Epirubicin—breast cancer	1.43e-05	7.19e-05	CcSEcCtD
Boceprevir—Pruritus—Epirubicin—breast cancer	1.41e-05	7.09e-05	CcSEcCtD
Boceprevir—Dizziness—Methotrexate—breast cancer	1.41e-05	7.08e-05	CcSEcCtD
Boceprevir—Diarrhoea—Epirubicin—breast cancer	1.37e-05	6.85e-05	CcSEcCtD
Boceprevir—Hypersensitivity—Doxorubicin—breast cancer	1.36e-05	6.83e-05	CcSEcCtD
Boceprevir—Vomiting—Methotrexate—breast cancer	1.36e-05	6.81e-05	CcSEcCtD
Boceprevir—Rash—Methotrexate—breast cancer	1.34e-05	6.75e-05	CcSEcCtD
Boceprevir—Dermatitis—Methotrexate—breast cancer	1.34e-05	6.74e-05	CcSEcCtD
Boceprevir—Headache—Methotrexate—breast cancer	1.34e-05	6.71e-05	CcSEcCtD
Boceprevir—Asthenia—Doxorubicin—breast cancer	1.32e-05	6.65e-05	CcSEcCtD
Boceprevir—Dizziness—Epirubicin—breast cancer	1.32e-05	6.62e-05	CcSEcCtD
Boceprevir—Pruritus—Doxorubicin—breast cancer	1.31e-05	6.56e-05	CcSEcCtD
Boceprevir—Vomiting—Epirubicin—breast cancer	1.27e-05	6.37e-05	CcSEcCtD
Boceprevir—Nausea—Methotrexate—breast cancer	1.27e-05	6.36e-05	CcSEcCtD
Boceprevir—Diarrhoea—Doxorubicin—breast cancer	1.26e-05	6.34e-05	CcSEcCtD
Boceprevir—Rash—Epirubicin—breast cancer	1.26e-05	6.32e-05	CcSEcCtD
Boceprevir—Dermatitis—Epirubicin—breast cancer	1.26e-05	6.31e-05	CcSEcCtD
Boceprevir—Headache—Epirubicin—breast cancer	1.25e-05	6.28e-05	CcSEcCtD
Boceprevir—Dizziness—Doxorubicin—breast cancer	1.22e-05	6.13e-05	CcSEcCtD
Boceprevir—Nausea—Epirubicin—breast cancer	1.19e-05	5.95e-05	CcSEcCtD
Boceprevir—Vomiting—Doxorubicin—breast cancer	1.17e-05	5.89e-05	CcSEcCtD
Boceprevir—Rash—Doxorubicin—breast cancer	1.16e-05	5.84e-05	CcSEcCtD
Boceprevir—Dermatitis—Doxorubicin—breast cancer	1.16e-05	5.84e-05	CcSEcCtD
Boceprevir—Headache—Doxorubicin—breast cancer	1.16e-05	5.81e-05	CcSEcCtD
Boceprevir—Nausea—Doxorubicin—breast cancer	1.1e-05	5.51e-05	CcSEcCtD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC2A1—breast cancer	6.56e-06	4.86e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SULT1A1—breast cancer	6.54e-06	4.84e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPX4—breast cancer	6.54e-06	4.84e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—breast cancer	6.5e-06	4.82e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SYNJ2—breast cancer	6.47e-06	4.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	6.45e-06	4.78e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	6.43e-06	4.77e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—breast cancer	6.41e-06	4.74e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—IDH1—breast cancer	6.39e-06	4.73e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTA1—breast cancer	6.39e-06	4.73e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	6.38e-06	4.73e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—breast cancer	6.35e-06	4.71e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NAT2—breast cancer	6.32e-06	4.68e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDH7A1—breast cancer	6.29e-06	4.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDH1A1—breast cancer	6.29e-06	4.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	6.24e-06	4.62e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	6.22e-06	4.61e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—breast cancer	6.14e-06	4.55e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	6.09e-06	4.51e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADSL—breast cancer	6.03e-06	4.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NME1—breast cancer	6.03e-06	4.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—UMPS—breast cancer	6.03e-06	4.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FHL2—breast cancer	6.03e-06	4.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PHGDH—breast cancer	6.03e-06	4.47e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NDUFS3—breast cancer	6.01e-06	4.45e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—NCOA1—breast cancer	6e-06	4.44e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—breast cancer	5.93e-06	4.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LDHB—breast cancer	5.91e-06	4.38e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HPSE—breast cancer	5.91e-06	4.38e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BRIP1—breast cancer	5.91e-06	4.38e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PLG—breast cancer	5.84e-06	4.33e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	5.77e-06	4.27e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—breast cancer	5.67e-06	4.2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CHST9—breast cancer	5.65e-06	4.19e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—breast cancer	5.64e-06	4.18e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	5.62e-06	4.16e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA3—breast cancer	5.6e-06	4.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMMR—breast cancer	5.6e-06	4.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCC1—breast cancer	5.6e-06	4.15e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—DPYD—breast cancer	5.54e-06	4.1e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MED12—breast cancer	5.54e-06	4.1e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—breast cancer	5.46e-06	4.04e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALDOA—breast cancer	5.45e-06	4.04e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARGC1B—breast cancer	5.43e-06	4.02e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	5.39e-06	3.99e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—COX11—breast cancer	5.36e-06	3.97e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	5.32e-06	3.94e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NCOA3—breast cancer	5.29e-06	3.92e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC2A2—breast cancer	5.25e-06	3.89e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—breast cancer	5.23e-06	3.88e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—breast cancer	5.22e-06	3.87e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	5.17e-06	3.83e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	5.16e-06	3.82e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCG2—breast cancer	5.15e-06	3.81e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTR—breast cancer	5.15e-06	3.81e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CPT1A—breast cancer	5.15e-06	3.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CA9—breast cancer	5.13e-06	3.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA4—breast cancer	5.13e-06	3.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	5.06e-06	3.75e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HPGDS—breast cancer	5.05e-06	3.74e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HBA1—breast cancer	5.02e-06	3.72e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—breast cancer	5e-06	3.7e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA2—breast cancer	5e-06	3.7e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX2—breast cancer	5e-06	3.7e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX4—breast cancer	4.93e-06	3.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SULT1A1—breast cancer	4.93e-06	3.66e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SHMT1—breast cancer	4.9e-06	3.63e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CDA—breast cancer	4.9e-06	3.63e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTT1—breast cancer	4.9e-06	3.63e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ACHE—breast cancer	4.9e-06	3.63e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—IDH1—breast cancer	4.82e-06	3.57e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA1—breast cancer	4.82e-06	3.57e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	4.82e-06	3.57e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	4.78e-06	3.54e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NAT2—breast cancer	4.77e-06	3.53e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A5—breast cancer	4.72e-06	3.49e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLCO1B1—breast cancer	4.72e-06	3.49e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP17A1—breast cancer	4.64e-06	3.43e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—breast cancer	4.61e-06	3.41e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS1—breast cancer	4.59e-06	3.4e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ENO1—breast cancer	4.59e-06	3.4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APRT—breast cancer	4.56e-06	3.38e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2D6—breast cancer	4.5e-06	3.33e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NCOA2—breast cancer	4.42e-06	3.27e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	4.39e-06	3.25e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ESRRA—breast cancer	4.28e-06	3.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ANGPTL4—breast cancer	4.28e-06	3.17e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—FASN—breast cancer	4.28e-06	3.17e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BCHE—breast cancer	4.27e-06	3.16e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	4.25e-06	3.15e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC5A5—breast cancer	4.21e-06	3.12e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MED12—breast cancer	4.18e-06	3.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—DPYD—breast cancer	4.18e-06	3.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDOA—breast cancer	4.11e-06	3.05e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NQO1—breast cancer	4.07e-06	3.01e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC2A1—breast cancer	4.07e-06	3.01e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HADHB—breast cancer	4.06e-06	3.01e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPI—breast cancer	4.06e-06	3.01e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NCOA3—breast cancer	3.99e-06	2.96e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP3A4—breast cancer	3.97e-06	2.94e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC2A2—breast cancer	3.97e-06	2.94e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1B1—breast cancer	3.9e-06	2.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTR—breast cancer	3.88e-06	2.88e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CPT1A—breast cancer	3.88e-06	2.88e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCG2—breast cancer	3.88e-06	2.88e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.87e-06	2.87e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.87e-06	2.87e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HSP90AA1—breast cancer	3.83e-06	2.83e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HPGDS—breast cancer	3.81e-06	2.82e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HBA1—breast cancer	3.79e-06	2.8e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NCOA1—breast cancer	3.72e-06	2.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UMPS—breast cancer	3.71e-06	2.75e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FHL2—breast cancer	3.71e-06	2.75e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADSL—breast cancer	3.71e-06	2.75e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NME1—breast cancer	3.71e-06	2.75e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PHGDH—breast cancer	3.71e-06	2.75e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTT1—breast cancer	3.7e-06	2.74e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ACHE—breast cancer	3.7e-06	2.74e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP19A1—breast cancer	3.67e-06	2.72e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—STK11—breast cancer	3.67e-06	2.72e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HPSE—breast cancer	3.64e-06	2.7e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BRIP1—breast cancer	3.64e-06	2.7e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LDHB—breast cancer	3.64e-06	2.7e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	3.59e-06	2.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP17A1—breast cancer	3.5e-06	2.59e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ENO1—breast cancer	3.46e-06	2.56e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS1—breast cancer	3.46e-06	2.56e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCC1—breast cancer	3.45e-06	2.56e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA3—breast cancer	3.45e-06	2.56e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMMR—breast cancer	3.45e-06	2.56e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—COMT—breast cancer	3.41e-06	2.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2D6—breast cancer	3.4e-06	2.52e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTP1—breast cancer	3.39e-06	2.51e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMOX1—breast cancer	3.35e-06	2.48e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.34e-06	2.48e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ITPR1—breast cancer	3.34e-06	2.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NCOA2—breast cancer	3.33e-06	2.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	3.24e-06	2.4e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FASN—breast cancer	3.23e-06	2.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BCHE—breast cancer	3.22e-06	2.38e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCB1—breast cancer	3.21e-06	2.38e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A5—breast cancer	3.18e-06	2.36e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA4—breast cancer	3.16e-06	2.34e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CA9—breast cancer	3.16e-06	2.34e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TYMS—breast cancer	3.16e-06	2.34e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLA2G4A—breast cancer	3.12e-06	2.31e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NCOR1—breast cancer	3.12e-06	2.31e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—breast cancer	3.12e-06	2.31e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA2—breast cancer	3.08e-06	2.28e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX2—breast cancer	3.08e-06	2.28e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC2A1—breast cancer	3.07e-06	2.27e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NQO1—breast cancer	3.07e-06	2.27e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX4—breast cancer	3.04e-06	2.25e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SULT1A1—breast cancer	3.04e-06	2.25e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP3A4—breast cancer	2.99e-06	2.22e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPX1—breast cancer	2.99e-06	2.21e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA1—breast cancer	2.97e-06	2.2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—IDH1—breast cancer	2.97e-06	2.2e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1A1—breast cancer	2.96e-06	2.19e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1B1—breast cancer	2.94e-06	2.18e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NAT2—breast cancer	2.94e-06	2.17e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ERCC2—breast cancer	2.93e-06	2.17e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	2.93e-06	2.17e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSP90AA1—breast cancer	2.89e-06	2.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NCOA1—breast cancer	2.81e-06	2.08e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—STK11—breast cancer	2.77e-06	2.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP19A1—breast cancer	2.77e-06	2.05e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTHFR—breast cancer	2.76e-06	2.04e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DPYD—breast cancer	2.57e-06	1.91e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MED12—breast cancer	2.57e-06	1.91e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—COMT—breast cancer	2.57e-06	1.91e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTP1—breast cancer	2.56e-06	1.9e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAV1—breast cancer	2.54e-06	1.88e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDOA—breast cancer	2.53e-06	1.88e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMOX1—breast cancer	2.53e-06	1.87e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ITPR1—breast cancer	2.52e-06	1.87e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NCOA3—breast cancer	2.46e-06	1.82e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A2—breast cancer	2.44e-06	1.81e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CPT1A—breast cancer	2.39e-06	1.77e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTR—breast cancer	2.39e-06	1.77e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCG2—breast cancer	2.39e-06	1.77e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TYMS—breast cancer	2.38e-06	1.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—breast cancer	2.35e-06	1.74e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NCOR1—breast cancer	2.35e-06	1.74e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLA2G4A—breast cancer	2.35e-06	1.74e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HPGDS—breast cancer	2.35e-06	1.74e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HBA1—breast cancer	2.33e-06	1.73e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CG—breast cancer	2.32e-06	1.72e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTT1—breast cancer	2.28e-06	1.69e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ACHE—breast cancer	2.28e-06	1.69e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX1—breast cancer	2.25e-06	1.67e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1A1—breast cancer	2.23e-06	1.65e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ERCC2—breast cancer	2.21e-06	1.64e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP17A1—breast cancer	2.15e-06	1.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS1—breast cancer	2.13e-06	1.58e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ENO1—breast cancer	2.13e-06	1.58e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2D6—breast cancer	2.09e-06	1.55e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTHFR—breast cancer	2.08e-06	1.54e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NCOA2—breast cancer	2.05e-06	1.52e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CD—breast cancer	2.04e-06	1.51e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—breast cancer	2.01e-06	1.49e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FASN—breast cancer	1.99e-06	1.48e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BCHE—breast cancer	1.98e-06	1.47e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A5—breast cancer	1.96e-06	1.45e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NOS3—breast cancer	1.92e-06	1.42e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAV1—breast cancer	1.92e-06	1.42e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NQO1—breast cancer	1.89e-06	1.4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A1—breast cancer	1.89e-06	1.4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1B1—breast cancer	1.81e-06	1.34e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.78e-06	1.32e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CB—breast cancer	1.77e-06	1.31e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—breast cancer	1.76e-06	1.3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CG—breast cancer	1.75e-06	1.29e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NCOA1—breast cancer	1.73e-06	1.28e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP19A1—breast cancer	1.71e-06	1.26e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—STK11—breast cancer	1.71e-06	1.26e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—COMT—breast cancer	1.59e-06	1.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTP1—breast cancer	1.58e-06	1.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMOX1—breast cancer	1.56e-06	1.15e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ITPR1—breast cancer	1.55e-06	1.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CD—breast cancer	1.54e-06	1.14e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—breast cancer	1.53e-06	1.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—breast cancer	1.52e-06	1.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCB1—breast cancer	1.49e-06	1.11e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TYMS—breast cancer	1.47e-06	1.09e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NOS3—breast cancer	1.45e-06	1.07e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NCOR1—breast cancer	1.45e-06	1.07e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.45e-06	1.07e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—breast cancer	1.45e-06	1.07e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX1—breast cancer	1.39e-06	1.03e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1A1—breast cancer	1.37e-06	1.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ERCC2—breast cancer	1.36e-06	1.01e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CB—breast cancer	1.34e-06	9.92e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—breast cancer	1.33e-06	9.83e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTHFR—breast cancer	1.28e-06	9.49e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAV1—breast cancer	1.18e-06	8.76e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—breast cancer	1.16e-06	8.57e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—breast cancer	1.08e-06	8.01e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CG—breast cancer	1.08e-06	7.98e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CD—breast cancer	9.47e-07	7.01e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—breast cancer	9.34e-07	6.92e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NOS3—breast cancer	8.94e-07	6.62e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—breast cancer	8.84e-07	6.55e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CB—breast cancer	8.25e-07	6.11e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—breast cancer	8.17e-07	6.06e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—breast cancer	8.16e-07	6.05e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—breast cancer	7.13e-07	5.28e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—breast cancer	6.67e-07	4.94e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—breast cancer	5.03e-07	3.73e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—breast cancer	4.11e-07	3.04e-06	CbGpPWpGaD
